Abstract
P215 - Risk assessment in humans using physiologically based pharmacokinetic model of diisobutyl phthalate and its major metabolite, monoisobutyl phthalate: Development and evaluation of model
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have